DEBIO 1143
CAS No. 1071992-99-8
DEBIO 1143 ( AT-406;DEBIO1143;SM406;ARRY-334543;D1143 )
Catalog No. M10293 CAS No. 1071992-99-8
DEBIO 1143 (AT-406, DEBIO-1143, SM406, ARRY-334543, D1143) is potent, orally active Smac mimetic that antagonizes cIAP1, cIAP2 and XIAP with Ki of 66.4, 1.9 and 5.1 nM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 47 | In Stock |
|
5MG | 77 | In Stock |
|
10MG | 120 | In Stock |
|
25MG | 264 | In Stock |
|
50MG | 498 | In Stock |
|
100MG | 707 | In Stock |
|
500MG | 1251 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDEBIO 1143
-
NoteResearch use only, not for human use.
-
Brief DescriptionDEBIO 1143 (AT-406, DEBIO-1143, SM406, ARRY-334543, D1143) is potent, orally active Smac mimetic that antagonizes cIAP1, cIAP2 and XIAP with Ki of 66.4, 1.9 and 5.1 nM, respectively.
-
DescriptionDEBIO 1143 (AT-406, DEBIO-1143, SM406, ARRY-334543, D1143) is potent, orally active Smac mimetic that antagonizes cIAP1, cIAP2 and XIAP with Ki of 66.4, 1.9 and 5.1 nM, respectively; effectively antagonizes XIAP BIR3 protein in cell-free functional assays, induces rapid degradation of cellular cIAP1 protein, and inhibits cancer cell growth in various human cancer cell lines; effectively induces apoptosis and causes complete inhibition of tumor growth apoptosis in xenograft tumors.Ovarian Cancer Phase 2 Clinical
-
SynonymsAT-406;DEBIO1143;SM406;ARRY-334543;D1143
-
PathwayOthers
-
TargetOther Targets
-
RecptorcIAP1-BIR3;cIAP2-BIR3;XIAP-BIR3
-
Research AreaCancer
-
IndicationOvarian Cancer
Chemical Information
-
CAS Number1071992-99-8
-
Formula Weight561.73
-
Molecular FormulaC32H43N5O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 93 mg/mL (165.6 mM); Ethanol: 93 mg/mL (165.6 mM); Water: <1 mg/mL ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESCC(C)CC(=O)N1CCC2CCC(N2C(=O)C(C1)NC(=O)C(C)NC)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4
-
Chemical Name(5S,8S,10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cai Q, et al. J Med Chem. 2011 Apr 28;54(8):2714-26.
2. Langdon CG, et al. Oncotarget. 2015 Nov 10;6(35):37410-25.
3. Tao Z, et al. Clin Cancer Res. 2018 Oct 23. doi: 10.1158/1078-0432.
4. Thibault B, et al. Sci Rep. 2018 Dec 14;8(1):17862.
2. Langdon CG, et al. Oncotarget. 2015 Nov 10;6(35):37410-25.
3. Tao Z, et al. Clin Cancer Res. 2018 Oct 23. doi: 10.1158/1078-0432.
4. Thibault B, et al. Sci Rep. 2018 Dec 14;8(1):17862.
molnova catalog
related products
-
trans-Benzylideneace...
trans-4-Phenyl-3-buten-2-one is used in various synthetic preparations.
-
8-epi-Confertin
The herbs of Inula hupehensis.
-
Bromodeoxyuridine (B...
Bromodeoxyuridine (BrdU) is a nucleoside analog that competes with thymidine for incorporation into DNA, and used in the detection of proliferating cells.